IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
Abstract Background Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2017-08-01
|
| coleção: | Arthritis Research & Therapy |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13075-017-1389-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|